← Back to catalogue

Ortho Rehab Absolut links

EUDAMED

Class I (EU MDR)

Ref 45621Model Achillesschuhe

by Künzli SwissSchuh AG

Identity

Trade Name
Ortho Rehab Absolut links EUDAMED
Device Name
Ortho Rehab Total EUDAMED
Model / Reference
Achillesschuhe EUDAMED
45621 EUDAMED

Identifiers

Primary DI / UDI-DI
07630042810362 EUDAMED
07630042810430 EUDAMED
07630042810447 EUDAMED
07630042810409 EUDAMED
07630042810416 EUDAMED
07630042810379 EUDAMED
07630042810386 EUDAMED
Basic UDI-DI
76300428AchillesschuheLS EUDAMED
EMDN Code
Y063303 READY-MADE ORTHOTIC SHOES EUDAMED

Classification

Device Class
Class I EUDAMED
Market of Registration
Germany EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

Yes

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Ortho Rehab Absolut links by Künzli SwissSchuh AG — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CH-MF-000044954
Authorised Representative
Axxos GmbH DE-AR-000005590

Sources (7)

  • EUDAMED fc2d4417-9bee-4673-8ee4-e917d2b990a8 61 fields · synced Oct 6, 2026
  • EUDAMED bcdff235-29b1-4415-ad87-02a39516015c 61 fields · synced May 17, 2026
  • EUDAMED 589c7519-1f9b-45d6-a0a7-ad6cf357f748 61 fields · synced May 19, 2026
  • EUDAMED 87a971ab-e545-4473-a32e-ee064d5548d4 61 fields · synced May 19, 2026
  • EUDAMED ed3f04ca-a52e-416b-a2ca-a518dfbaa41e 61 fields · synced May 19, 2026
  • EUDAMED b51b7b49-1f9b-462c-b415-d4f3fafcddec 61 fields · synced May 19, 2026
  • EUDAMED 7d8c8b1d-c231-474b-8226-fbc9d9d1c547 61 fields · synced May 19, 2026